|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/17 | |
| A61P 19/02 | |||
| C07K 14/705 |
| (11) | Patento numeris | 2563385 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11778000.7 |
| Europos patento paraiškos padavimo data | 2011-04-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-03-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-08-02 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/034282 |
| Data | 2011-04-28 |
| (87) | Numeris | WO 2011/139820 |
| Data | 2011-11-10 |
| (30) | Numeris | Data | Šalis |
| 329078 P | 2010-04-28 | US |
| (72) |
ZHENG, Xincheng, US
WU, Wei, US
LIU, Yang, US
ZHENG, Pan, US
|
| (73) |
Oncoimmune Inc.,
12111 Parklawn Drive, Suite 107, Rockville MD 20852-1707,
US
|
| (54) | METHODS OF USE OF SOLUBLE CD24 FOR THERAPY OF RHEUMATOID ARTHRITIS |
| METHODS OF USE OF SOLUBLE CD24 FOR THERAPY OF RHEUMATOID ARTHRITIS |